Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 13, 2019

SELL
$56.04 - $82.66 $520,331 - $767,498
-9,285 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$48.29 - $80.6 $448,372 - $748,371
9,285 New
9,285 $733,000
Q1 2018

May 17, 2018

SELL
$39.82 - $57.53 $1.78 Million - $2.57 Million
-44,640 Closed
0 $0
Q4 2017

Feb 15, 2018

BUY
$46.49 - $60.51 $2.08 Million - $2.7 Million
44,640
44,640 $2.35 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $11.8B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Doheny Asset Management /Ca Portfolio

Follow Doheny Asset Management /Ca and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Doheny Asset Management /Ca, based on Form 13F filings with the SEC.

News

Stay updated on Doheny Asset Management /Ca with notifications on news.